MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3. Based on MedDRA version.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactio

Size: px
Start display at page:

Download "MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3. Based on MedDRA version.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactio"

Transcription

1 MedDRA R 3.5 MedDRA Version 8.1 MedDRA /

2 MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3. Based on MedDRA version.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactions / Adverse Events & Medical and Social History & Indications 7 November 2005

3 Copyright ICH Secretariat (c/o IFPMA) Copying is permitted, with reference to source, but material in this publication may not be used in any documentation or electronic media which is offered for sale, without the prior permission of the copyright owner. IFPMA Chemin Louis-Dunant, 15 P.O. Box Geneva 20 Switzerland Tel: +41 (22) Fax: +41 (22) JMO

4 MedDRA LLT

5 ICH Points to Consider :...23 Tetsuya Kusakabe ICH Points to Consider...24

6 1.0 ICH MedDRA) 1) MedDRA MedDRA Term Selection:Points to Consider(PTC) ICH MedDRA ICH MedDRA MedDRA EU USA MSSO JMO 4.0 MedDRA V Points to Consider MedDRA Points to Consider MedDRA MedDRA

7 1.2 MedDRA (safety signals) / ADR/AE 2 ADR/AE ADR/AE 1.3 MedDRA Points to Consider MedDRA MedDRA MedDRA PTC MedDRA MedDRA MedDRA MedDRA (MedDRA) MedDRA Introductory Guide 1.4 ADR/AE ) ADR/AE ICH CIOMS

8 (LLT) 2.3 LLT ( )LLT ( ) MedDRA MedDRA MSSO (change request) HIV viral load increased MedDRA

9 2.4.3 MedDRA brittle hair Hair texture abnormal Hair disorder MedDRA MSSO (metastatic gallbladder cancer) MedDRA (Gallbladder cancer) ADR/AE, ( abdominal pain) ( increased serum amylase) (increased serum lipase) (Pancreatitis)

10 2.5.3 (anaphylactic reaction) (rash) (dyspnea) (hypotension) (laryngospasm) (Anaphylactic reaction) (myocardial infarction) (chest pain) (dyspnea), (diaphoresis) ECG (ECG changes) (jaundice) (Myocardial infarction) (Jaundice) 2.6 Points to Consider MedDRA MedDRA MedDRA MedDRA SOC MedDRA MSSO MedDRA VIII (Factor deficiency) SOC SOC SOC

11 possible myocardial infarction Myocardial infarction (chest pain) (dyspnea) (diaphoresis) (jaundice) (possible myocardial infarction) (myocardial infarction) (jaundice) (chest pain) (dyspnea) (diaphoresis) (jaundice) (possible myocardial infarction) (chest pain) (dyspnea) (diaphoresis) (jaundice) pulmonary embolism (myocardial infarction) (congestive heart failure) Pulmonary embolism (Myocardial infarction) (Congestive heart failure)

12 3.1.4 : (chest pain) (cyanosis) (shortness of breath) (blood pressure decreased) (pulmonary embolism) (myocardial infarction) (congestive heart failure) (Chest pain) (Cyanosis) (Shortness of breath) (Blood pressure decreased) : (pulmonary embolism) (myocardial infarction) (congestive heart failure) (chest pain) (cyanosis) (shortness of breath) (blood pressure decreased) (Chest pain) (Cyanosis) (Shortness of breath) (Blood pressure decreased) (Pulmonary embolism) (Myocardial infarction) (Congestive heart failure) 3.2 ADR/AE ADR/AE ADR/AE (death due to myocardial infarction) (Myocardial infarction) ADR/AE MedDRA : (constipation) (ruptured bowel) (peritonitis) (sepsis) (patient died) (Constipation) (Perforated bowel) (Peritonitis) (Sepsis) : (a patient was found dead) (Found dead) ADR/AE ADR/AE : (hospitalization due to congestive heartfailure) ADR/AE (Congestive heartfailure) (Hospitalization) : (a patient was hospitalized) Hospitalisation

13 : 1.6mEq/L (hyperkalemia with a serum potassium of 1.6 meq/l) (Serum potassium abnormal) 1.6mEq/L : GU (GU pain) GU (genito-urinary) (gastric ulcer) (pain) (Pain) (patient experienced every listed adverse event) (Unevaluable event)

14 (arrhythmia due to atrial fibrillation) (Atrial fibrillation) (hepatic function disorder (acute hepatitis) ) (Hepatitis acute) MedDRA (retinopathy due to diabetes) (Diabetic retinopathy) (rash with itching) (Itchy rash) (diarrhea and vomiting) (Diarrhea) (Vomiting) DIC(DIC due to sepsis) DIC (Sepsis) (wrist fracture due to fall) (Wrist fracture) (Fall) MedDRA ; pain due to cancer Cancer pain JMO ; shortness of breath due to cancer (Shortness of breath)

15 MedDRA (skin rash on face) (Rash on face) MedDRA MedDRA (skin rash on chest) (Rash) PT (skin rash on face and neck) (Skin rash) MedDRA (pneumococcal pneumonia) (Pneumococcal pneumonia) MedDRA MedDRA (respiratory chlamydial infection) (Chlamydial infection) (respiratory chlamydial infection) (Respiratory infection) (respiratory chlamydial infection) (Chlamydial infection) (Respiratory infection) ADR/AE MedDRA (exacerbation of myasthenia gravis) (Myasthenia gravis aggravated)

16 MedDRA (halitosis worsened) (Halitosis) (Condition aggravated) (Disease progression (progression of Alzheimer s disease) (Alzheimer s disease) (Disease progression ) (aggravation of jaundice) (Jaundice) (Condition aggravated) MedDRA MSSO (MedDRA 8.1 )

17 3.8 MedDRA (congenital) MedDRA SOC (congenital heart disease) (child born with heart disease) (Heart disease congenital ) MedDRA (night blindness ) PT ( Night blindness ) (Night blindness) (cholangiectasis) (Cholangiectasis acquired) 3.9 SOC ADR/AE SOC (patient had gallbladder surgery) (Gallbladder operation ) (patient had tonsillectomy in childhood) (Tonsillectomy)

18 3.9.2 ADR/AE (liver tranlplantation due to liver failure) (Liver failure) (Liver failure) (Liver transplantation) JMO LLT Liver transplantation N LLT/PT: Liver transplant (surgery for bleeding gastric ulcer) (Bleeding gastric ulcer) (Bleeding gastric ulcer) (Gastric surgery) 3.10 SOC (increased) (decreased) (abnormal) (normal) hyperhypo SOC SOC SOC SOC E2b B.3.1c. bilirubin test Bilirubin (cardiac output) (Cardiac ADR/AE (hypoglycemia) (Hypoglycemia) (Hypoglycemia) SOC (decreased glucose) (Glucose decreased) (Glucose decreased) SOC mg/dl(glucose 40 mg/dl) (Glucose low) (his glucose was 40) (Glucose abnormal)

19 K7.0mmol/L (elevated potassium, K7.0 mmol/l and hyperkalemia) (Hyperkalemia) mmol/L (alopecia, rash, and elevated potassium 7.0 mmol/l) (Alopecia) (Rash) (Potassium increased) (abnormal liver function tests) (Abnormal liver function tests) SGPT SGOT LDH (increased alkaline phosphatase, increased SGPT, increased SGOT, and elevated LDH) 4 (Liver function tests abnormal) 1 4

20 3.11 MedDRA 8.0 HLGT HLT HLT ( Maladministrations ) HLT ( Medication monitoring errors ) HLT ( Overdoses ) HLT ( Medication errors due to accidental exposures ) HLT ( Medication errors NEC ) JMO term(s) for the medication error and the clinical consequences should be selected hives due to medication error Hives ( Medication error) ADR/AE (medication was given intravenously instead of intramuscularly) (Intramuscular formulation administered by other route) (nurse splashed an injectable drug in her eye) (Inadvertent exposure to drug) (child exposed to drug during breast feeding) (Drug exposure via

21 breast milk) ( No adverse effect) 3.14 (medication was given intravenously instead of intramuscularly without sequelae) (Intramuscular formulation administered by other route) (No adverse effect) MedDRA Overdose Toxicity Poisoning HLT Overdoses HLT (Poisoning and toxicity) MedDRA Version 8.1 (overdose of pills) (Overdose) (stomach upset from study drug overdose) (Stomach upset) (Overdose) (Overdose) (No adverse effect) ( MedDRA (torsade de pointes with suspected drug interaction) (Torsade de pointes) (Drug interaction) (patient was started on an anit-seizure and heart medication and developed syncope) (Syncope) (patient was already on anti-seizure medication and was started on a heart medication and anti-seuzure medicaiton levels increased) (Drug)

22 (Anticonvulsant level increased) 3.14 (No adverse effect) ADR/AE MedDRA (Normal baby) (Normal electrocardiogram) (Sinus rhythm)

23 3.15 ADR/AE (a bold patient was pleased that he grew hair while using a product) (Unexpected therapeutic effect) (Hair growth increased) 3.16 ADR/AE MedDRA (antibiotic didn t work) (Lack of drug effect) (patient took drug, her headache didn t go away, drug is ineffective) (Drug ineffective) (an epilectic patient took an anti-convulsant, but the seizures continued unchanged) (Lack of drug effect) HIV AIDS (AIDS patient taking anti-hiv drug died) (Lack of drug effect)

24 Increased Decreased Prolonged A (patient had increased effect from drug A) (Increased drug effect) A (patient had decreased effect from drug A) (Drug effect decreased) A (patient had prolonged effect from drug A) (Drug effect prolonged) 3.17 SOC SOC ADR/AE ADR/AE SOC (patient was abusing an analgesic) (Analgesic abuse) SOC MedDRA SOC (Disorder) SOC ADR/AE SOC Social Circumstances SOC SOC Disorder SOC (Alcoholic ) (Alcoholism) (Drug addict) (Drug addiction )

25 3.18 MedDRA (history of gastrointestinal bleed and hysterectomy) (Gastrointestinal bleed) (Hysterectomy) (patient is a cigarette smoker with coronary artery disease) (Cigarette smoker) (Coronary artery disease) 3.19 weight loss (Weight loss) immunosuppression (Immunosuppression )

26 hypertension (Hypertension) anti-hypertensive (Hypertension) chemotherapy for breast cancer (Breast cancer) (medication for gastrointestinal problem) ( Gastrointestinal disorder) MedDRA a patient had received chemotherapy Chemotherapy Prevention and Prophylaxis MedDRA prevention prophylaxis (arrhythmia prophylaxis) (Arrhythmia prophylaxis) prevention of migraine (Migraine prophylaxis) (prevention of hepatotoxicity) (Hepatotoxicity) (prevention of hepatotoxicity) (Prevention) (prevention of miscarriage) (Prevention) (Hepatotoxicity) contrast agent for angiogram (Angiogram ) contrast agent for coronary angiogram ( Coronary angiogram) (induction of anesthesia) (Induction of anesthesia)

27 SOC 3.9 testosterone replacement therapy (Androgen replacement therapy) thyroid replacement therapy (Thyroxine therapy) prenatal vitamin (Vitamin supplementation) (Drug use for unknown indication) (aspirin was taken for an unknown indication) (Drug use for unknown indication)

28 ICH Points to Consider : Rapporteur: Reinhard Fescharek Japan: Ministry of Health, Labour and Welfare: Tatsuo Kishi Tetsuya Kusakabe Japan Pharmaceutical Manufacturers Association Takayoshi Ichikawa Yo Tanaka Japanese Maintenance Organization Reiji Tezuka Yasuo Sakurai European Union: Commission of the European Communities Dolores Montero Carmen Kreft-Jais European Federation of Pharmaceutical Industries Associations Reinhard Fescharek Christina Winter Canada: Health Canada Bill Wilson United States: US Food and Drug Administration John (Jake) Kelsey Toni Piazza-Hepp

29 Pharmaceutical Research and Manufacturers of America Susan M. Lorenski JoAnn Medbery MedDRA MSSO Patricia Mozzicato 4.2 ICH Points to Consider Japan: Ministry of Health, Labour and Welfare Tamaki Fushimi Kazuhiro Kemmotsu Chie Kojima Emiko Kondo Kemji Kuramochi Takashi Yasukawa Kaori Nomura Kenichi Tamiya Manabu Yamamoto Japan Pharmaceutical Manufacturers Association Akemi Ishikawa Satoru Mori Yasuo Sakurai Kunikazu Yokoi Japanese Maintenance Organization Yuki Tada Akemi Ishikawa Canada: Health Canada Heather Morrison

30 European Union: European Federation of Pharmaceutical Industries Associations Barry Hammond past Rapporteur United States: US Food and Drug Administration Miles Braun Brad Leissa Andrea Feight Pharmaceutical Research and Manufacturers of America David Goldsmith Sidney Kahn Margaret M. Westland past Rapporteur MedDRA MSSO: JoAnn Medbery

MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.1 Based on MedDRA version 5.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reac

MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.1 Based on MedDRA version 5.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reac MedDRA 3.1 MedDRA V.5.1 MedDRA / 2002 9 12 MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.1 Based on MedDRA version 5.1 ICH-Endorsed Guide for MedDRA Users Application to Adverse Drug Reactions /

More information

DatRetPrePTC_R1.4_J.doc

DatRetPrePTC_R1.4_J.doc MedDRA Release 1.4 MedDRA 10.1 ICH MedDRA 2007 912 MedDRA DATA RETRIEVAL AND PRESENTATION: POINTS TO CONSIDER Release 1.4 Based on MedDRA Version 10.1 ICH-Endorsed Guide for MedDRA Users on Data Output

More information

Microsoft Word - TermSelPTC_R4.6SoC_sep2013 Japanese revise.docx

Microsoft Word - TermSelPTC_R4.6SoC_sep2013 Japanese revise.docx Release 4.5 から 4.6 への主な変更点 MedDRA 用語選択 : 考慮事項 公表版 4.6 (MedDRA Version 16.1 対応 ) 2013 年 10 月 1 日 本資料は MedDRA 用語選択 : 考慮事項 の Release 4.5 から Release 4.6 への変更点を示したものである 文書全体 1) スペル 句読点等の修正 2) 参照する MedDRA をバージョン

More information

MedDRA 用語選択 : 考慮事項 公表版 3.14 (MedDRA Version 13.0 対応 ) ICH 活動で作成された MedDRA ユーザーのためのガイド 医薬品副作用 / 有害事象 および 医学的 社会的背景 適応症に対する適用 2010 年 4 月 1 日

MedDRA 用語選択 : 考慮事項 公表版 3.14 (MedDRA Version 13.0 対応 ) ICH 活動で作成された MedDRA ユーザーのためのガイド 医薬品副作用 / 有害事象 および 医学的 社会的背景 適応症に対する適用 2010 年 4 月 1 日 MedDRA 用語選択 : 考慮事項 公表版 3.14 (MedDRA Version 13.0 対応 ) ICH 活動で作成された MedDRA ユーザーのためのガイド 医薬品副作用 / 有害事象 および 医学的 社会的背景 適応症に対する適用 2010 年 4 月 1 日 MedDRA TERM SELECTION: POINTS TO CONSIDER Release 3.14 Based on

More information

スライド タイトルなし

スライド タイトルなし MedDRA 3 CRC 2004 4 24 NPO DSRU Japan kubotape-tky@umin.ac.jp MedDRA Medical Dictionary for Regulatory Activities Terminology MedDRA ICH: International Conference on Harmonisation SOC HLGT HLT PT LLT MedDRA

More information

Microsoft PowerPoint - LITA-noreflow_English.pptx

Microsoft PowerPoint - LITA-noreflow_English.pptx A case of no-reflow phenomenon during PCI to LIMA graft Iwatsuki-Minami hospital, Saitama, Japan Koichi Sano, Masaki Tsukagoshi, Yasunari Ueno, Seiichi Fukuda, Takayoshi Sato, Yasuyuki Maruyama 77 y.o.

More information

日本化学療法学会雑誌第61巻第4号

日本化学療法学会雑誌第61巻第4号 μ μ μ μ μ μ Key words I β μ Sex Age (years) Height (cm) Evaluation items Table1.Characteristics of patients 1. mg/kg/day (n14) 2.5 mg/kg/day (n9) 5. mg/kg/day (n9) Total (n32) male 12 8 7 27 female 2 1

More information

untitled

untitled CTCAE v3.0 JCOG/JSCO v1.0 Instructions and Guidelines for Japanese CTCAE v3.0 by JCOG and JSCO JCOG JCOG JCOG JCOG 2004 5 13 2004 7 1 2004 10 1 2004 10 27 JCOG http://www.jcog.jpjcog 0. 0.1. NCI Common

More information

JIPAD2015.pptx

JIPAD2015.pptx ICU 機能評価委員会報告 JIPAD update 2015 - 過去 現在 そして未来へ - 内野滋彦 東京慈恵会医科大学附属病院集中治療部 x 日本集中治療医学会学術集会 COI 開示 筆頭発表者 : 内野滋彦 1 役員 顧問職等の報酬 * 無 2 株式の利益 * ( または株式の5% 以上 ) 無 3 特許権使用料など * 無 4 講演料など * 無 5 原稿料など * 無 6 研究費 助成金など

More information

VOL.39 S-3

VOL.39 S-3 VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose

More information

日本化学療法学会雑誌第65巻第4号

日本化学療法学会雑誌第65巻第4号 Mycoplasma pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae M. pneumoniae Key words Mycoplasma pneumoniae Mycoplasma pneumoniae M. pneumoniae I M. pneumoniae M. pneumoniae M. pneumoniae

More information

操作ガイド(本体操作編)

操作ガイド(本体操作編) J-1 QT5-0681-V02 1 m a b c d e f l kj i h g a b c d e f g h i j k l m n n o o s p q r p q r s w t u v x y z t u v w x y z a bc d e f g q p o n m l k j i h a b c d e f g h i j k l {}[] {}[] m n

More information

Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin

Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamin Fig. 1 A: Effects of intramuscular injection of glucagon on the blood glucose levels (changes from basal, ƒ BG) as compared with effects of scopolamine butylbromide during upper gastrointestinal endoscopy.

More information

基本操作ガイド

基本操作ガイド HT7-0199-000-V.5.0 1. 2. 3. 4. 5. 6. 7. 8. 9. Copyright 2004 CANON INC. ALL RIGHTS RESERVED 1 2 3 1 1 2 3 4 1 2 1 2 3 1 2 3 1 2 3 1 2 3 4 1 2 3 4 1 2 3 4 5 AB AB Step 1 Step

More information

操作ガイド(本体操作編)

操作ガイド(本体操作編) J QT5-0571-V03 1 ...5...10...11...11...11...12...12...15...21...21...22...25...27...28...33...37...40...47...48...54...60...64...64...68...69...70...70...71...72...73...74...75...76...77 2 ...79...79...80...81...82...83...95...98

More information

日本職業・災害医学会会誌第54巻第6号

日本職業・災害医学会会誌第54巻第6号 Reprint request: A CASE OF PRESENTED VARIOUS FUNCTIONAL DISTURBANCES AFTER AN INJURY Taketoshi NOGAKI, Nobusuke HOUCHI, Tomoko SUGIUCHI, Naohiko WATANABE and Hiroyuki ZUSHO Department of Otolaryngology,

More information

明海大学歯学雑誌 37‐2/1.秦泉寺

明海大学歯学雑誌 37‐2/1.秦泉寺 J Meikai Dent Med 37, 153 158, 8 153 1 7 5ml /1 min Wong-Baker Face Rating Scale FS 5 1 9. g 3 5ml /1 min, FS 1 66 6ml /1 min FS 5 1 9. g 3 6ml /1 min, FS 3 Two Cases of Xerostomia that Showed an Improvement

More information

1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):

More information

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版 ...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

More information

スライド 1

スライド 1 1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00

More information

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, School of Medicine, Tokushima University, Tokushima Fetal

More information

Table 1 Profiles of 28 patients with Legionella pneumonia in Japan, 1980-1990 a) Y Taguchi, personal communication b) M. Hayase, personal communicatio

Table 1 Profiles of 28 patients with Legionella pneumonia in Japan, 1980-1990 a) Y Taguchi, personal communication b) M. Hayase, personal communicatio Key words: Legionella pneumonia, culture-positive, Japanese patients Legionella (L. pneumophila (L. micdadei, L. bozemanii, Table 1 Profiles of 28 patients with Legionella pneumonia in Japan, 1980-1990

More information

老人性不整脈

老人性不整脈 資料 : QOL CHADS NOAC はじめに common disease 高齢者の不整脈の頻度, AF AVB RBBB LBBB Cardiovascular Health Study, 137 表 1 Outpatient Atarashi Cardiovascular Health Study Monolio No F M Ectopic beats Supraventricular.

More information

Hirosaki University Repository 妊 娠 可 能 てんかん 女 性 の 治 療 管 理 基 準 設 定 に 関 する 研 Title 究 Author(s) 兼 子, 直 Citation てんかん 治 療 研 究 振 興 財 団 研 究 年 報. 4, 1992, p.24-35 Issue Date 1992 URL http://hdl.handle.net/10129/1905

More information

日本化学療法学会雑誌第60巻第4号

日本化学療法学会雑誌第60巻第4号 Streptococcus pneumoniae Haemophilus influenzae S. pneumoniae H. influenzae Key words β Streptococcus pneumoniae Haemophilus influenzae S. pneumoniae H. influenzae μ μ S. pneumoniae H. influenzae S. pneumoniae

More information

第61巻5・6号(12月号)/特集1頁目(本刷)

第61巻5・6号(12月号)/特集1頁目(本刷) Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture

More information

基本操作ガイド

基本操作ガイド HT7-0022-000-V.4.0 Copyright 2004 CANON INC. ALL RIGHTS RESERVED 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1 1 2 3 4 5 1 2 1 2 3 1 2 3 1 2 3 1 2 3 4 1 2 3 4 1 2 3 4 5 6 1 2 3 4 5 6 7 1 2 3 4

More information

11_渡辺_紀要_2007

11_渡辺_紀要_2007 56 1 19 Bull. Nara Univ. Educ., Vol. 56, No.1 (Cult. & Soc.), 2007 115 19 Why is Kidney Dysfunction Caused by Cadmium (Cadmium Nephropathy) not Officially Recognized as a Pollution-related Disease by the

More information

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This

More information

Copyright 2001, 1999, 1997, 1995, 1993, 1991, 1990 by The McGraw-Hill Companies, Inc. All rights reserved. Printed in the United States of America. Except as permitted under the United States Copyright

More information

2014-sougou_all.pdf

2014-sougou_all.pdf 37 Ministry of Health, Labour and Welfare 2014 38 Ministry of Health, Labour and Welfare 2014 39 Ministry of Health, Labour and Welfare 2014 40 Ministry of Health, Labour and Welfare 2014 Q1 A1 Q2 A2 Q3

More information

1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing

More information

特集・総説・報告(44行)/P045-055_報告 日本肝移植研究会

特集・総説・報告(44行)/P045-055_報告 日本肝移植研究会 45 Liver Transplantation in Japan in 2006 Part 2 Registry by the The Summary Four thousand three hundred thirty liver transplants have been performed as of December 31, 2006 in 59 institutions in Japan.

More information

The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi

The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursing Professionals for Diabetic Outpatients Not Using

More information

VOL. 36 S-3 CHEMOTHERAPY 437

VOL. 36 S-3 CHEMOTHERAPY 437 VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,

More information

202

202 201 Presenteeism 202 203 204 Table 1. Name Elements of Work Productivity Targeted Populations Measurement items of Presenteeism (Number of Items) Reliability Validity α α 205 α ä 206 Table 2. Factors of

More information

Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H.

Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H. Key words: Campylobacter fetus,meningitis Fig.1 Case 1,E.H.Clinical Course of Campylobacter Meningitis Table 1 Case 1.E.H. 273 昭 和61年3月20日 Table 2 Case 2.T.N. Fig.3 Case2,T.N.Clinical Campylobacter Fig.2

More information

Copyright 2002-2003 SATO International All rights reserved. http://www.satoworldwide.com/ This software is based in part on the work of the Independen

Copyright 2002-2003 SATO International All rights reserved. http://www.satoworldwide.com/ This software is based in part on the work of the Independen SATO Label Gallery SATO International Pte Ltd Version : BSI-021227-01 Copyright 2002-2003 SATO International All rights reserved. http://www.satoworldwide.com/ This software is based in part on the work

More information

VOL. 34 S-2 CHEMOTH8RAPY 913

VOL. 34 S-2 CHEMOTH8RAPY 913 VOL. 34 S-2 CHEMOTH8RAPY 913 914 CHEMOTHERAPY APR. 1986 Fig. 1 Chemical structure of T-2588 and T-2525 T- 2588 pivaloyloxymethyl (+ )- (6 R, 7 R)-7-[(Z)-2- (2-amino- 4-thiazolyl)-2-methox yiminoacetamido]-3-[(

More information

総 説 6 6 PIMs P S J 7

総 説 6 6 PIMs P S J 7 2018 10 1-6 総 説 2018 P S J 1 2018 10 7-13 総 説 6 6 PIMs P S J 7 2018 10 19-29 誌上シンポジウム JASDS DSM 1997 2012 15 DSM DSSP JASDS DSM DSSP P S J 19 2018 10 30-34 誌上シンポジウム ADME 30 Pharmacy Society of Japan 2018

More information

Medical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 7 (2009) Key words Use of food wrap or perforated polyethylene film as non-adherent dressing makes wound dressing simple

More information

ユーザーズマニュアル

ユーザーズマニュアル 1 2 3 This product (including software) is designed under Japanese domestic specifi cations and does not conform to overseas standards. NEC *1 will not be held responsible for any consequences resulting

More information

_’£”R‡Ù‡©

_’£”R‡Ù‡© 29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)

More information

小児感染免疫第25巻第2号

小児感染免疫第25巻第2号 Vol. 25No. 2145 1,2 1 1 1 1 2 2 2 TFLX 9 TFLX 450 mg16.6 mgkg TFLX 30 kg TFLX 2009 10 TFLX 1 1 2 3,4 TFLX 9 22 6 18 19 TFLX 450 mg150 mg 1 1 1 3 16.6 mgkg 20 20 0 21 3 135.0 cm0.1 S.D. 27.0 kg0.8 S.D.

More information

FA

FA 29 28 15 1985 1993 The process of the labor negotiations of the Japan Professional Baseball Players Association, 1985 1993 ABE Takeru Graduate School of Social Science, Hitotsubashi University Abstract

More information

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004

Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004 The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale

More information

インターネット接続ガイド v110

インターネット接続ガイド v110 1 2 1 2 3 3 4 5 6 4 7 8 5 1 2 3 6 4 5 6 7 7 8 8 9 9 10 11 12 10 13 14 11 1 2 12 3 4 13 5 6 7 8 14 1 2 3 4 < > 15 5 6 16 7 8 9 10 17 18 1 2 3 19 1 2 3 4 20 U.R.G., Pro Audio & Digital Musical Instrument

More information

2014Vol.63No.4p.383393 Thermal environment for health and safety Hirohumi HAYAMA Masaya SAITO Haruka MIKAMI Faculty of Engineering, Hokkaido University School of Design, Sapporo City University Graduate

More information

CHEMOTHERAPY FEB Table 1 Background of volunteers

CHEMOTHERAPY FEB Table 1 Background of volunteers CHEMOTHERAPY FEB. 1985 Table 1 Background of volunteers Table 3 Reproducibility of saisomicln In the EIA and the RIA Fig.1 Comparison of the EIA with the RIA or bioassay of sisomicin Table 4 Blood levels

More information

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

More information

慢性膵炎

慢性膵炎 - - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider

More information

05 ’łŒì†E„³›i†E‘tfiú

05 ’łŒì†E„³›i†E‘tfiú Child abuse and multiple problems in the process of family functional reunification concerning the Child Care Institution Kei Kanno Takuro Motonaga Takashi Kasuga Child raising environment has changed

More information

ユーザーズマニュアル

ユーザーズマニュアル 1 2 3 4 This product (including software) is designed under Japanese domestic specifications and does not conform to overseas standards. NEC *1 will not be held responsible for any consequences resulting

More information

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration

More information

P.1~18

P.1~18 JCM Copyright 2011 Japanese by JCM Copyright 2008 bymelvin W Wong Published by ARMOUR Publishing Pte Ltd Kent Ridge Post Office P.O.Box 1193,Singapore 911107 Email: mail@armourpublishing.com Website: www.armourpublising.com

More information

25 Removal of the fricative sounds that occur in the electronic stethoscope

25 Removal of the fricative sounds that occur in the electronic stethoscope 25 Removal of the fricative sounds that occur in the electronic stethoscope 1140311 2014 3 7 ,.,.,.,.,.,.,.,,.,.,.,.,,. i Abstract Removal of the fricative sounds that occur in the electronic stethoscope

More information

Core Ethics Vol. : - NICU : : - A B C D

Core Ethics Vol. : - NICU : : - A B C D Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D

More information

VOL. 17 NO. 7 CHEMOTHERAPY 1305 1) W. BRumFirr et al. : Clinical and laboratory studies with carbenicillin. Lancet 1: 1289~ 1293, 1967 2) E. T. KNUDSEN et al. : A new semisynthetic penicillin active against

More information

”Лï−wŁfl‰IŠv‚æ89“ƒ/‚qfic“NŸH

”Лï−wŁfl‰IŠv‚æ89“ƒ/‚qfic“NŸH March Servio P KURATA YASUMICHI, A Consideration on Change of Welfare Institutions for the Aged through the History of Japan JAPAN JOURNAL OF SOCIAL SERVICES, MAY, NUMBERJAPANESE SOCIETY FOR THE STUDY

More information

Huawei G6-L22 QSG-V100R001_02

Huawei  G6-L22 QSG-V100R001_02 G6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1 2 3 17 4 5 18 UI 100% 8:08 19 100% 8:08 20 100% 8:08 21 100% 8:08 22 100% 8:08 ********** 23 100% 8:08 Happy birthday! 24 S S 25 100% 8:08 26 http://consumer.huawei.com/jp/

More information

原著・報告・記録(44行)/P261~274_報告 肝移植症例登録

原著・報告・記録(44行)/P261~274_報告 肝移植症例登録 261 Liver Transplantation in Japan Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2013, a total of 7,474 liver transplants

More information

エレクトーンのお客様向けiPhone/iPad接続マニュアル

エレクトーンのお客様向けiPhone/iPad接続マニュアル / JA 1 2 3 4 USB TO DEVICE USB TO DEVICE USB TO DEVICE 5 USB TO HOST USB TO HOST USB TO HOST i-ux1 6 7 i-ux1 USB TO HOST i-mx1 OUT IN IN OUT OUT IN OUT IN i-mx1 OUT IN IN OUT OUT IN OUT IN USB TO DEVICE

More information

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin CHEMOTHERAPY CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin CHEMOTHERAPY Fig. 1 MICs of sultamicillin against respiratory pathogenic Branhamella catarrhalis 62 strains, inoculum size 106CFU/m1 Fig.

More information

iPhone/iPad接続マニュアル

iPhone/iPad接続マニュアル / JA 2 3 USB 4 USB USB i-ux1 USB i-ux1 5 6 i-mx1 THRU i-mx1 THRU 7 USB THRU 1 2 3 4 1 2 3 4 5 8 1 1 9 2 1 2 10 1 2 2 6 7 11 1 2 3 4 5 6 7 8 12 1 2 3 4 5 6 13 14 15 WPA Supplicant Copyright 2003-2009, Jouni

More information

原著・報告・記録(44行)/P156~169_報告 肝移植症例登録

原著・報告・記録(44行)/P156~169_報告 肝移植症例登録 156 Vol. 50, No. 23 Liver Transplantation in Japan Registry by the Japanese Liver Transplantation Society The Japanese Liver Transplantation Society Summary As of December 31, 2014, a total of 7,937 liver

More information

28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90

28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 2015 28 1 89 93 CT C3 Tb PCR XP WBC 7 600/mm 3 CRP 4 08mg/dl MRI MRI CT MRI WBC 9 700/mm 3 CRP 6 09mg/dl CT C3 C2 C7 low density area CT 89 28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90 28 1 4 CT C2 C7 low

More information

untitled

untitled 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 20021016 17 18 1018 19 20 21 22 23 24 25 1 11 ICHMedDRA/ J ver. 10.0Preferred Term 26 27 http://www.info.pmda.go.jp/ http://www.pmda.go.jp/index.html ICH MedDRA/Jver.11.1

More information

鷲谷先生寄贈リスト.PDF

鷲谷先生寄贈リスト.PDF 1939 1946 1958 1961 1980 1947 1953 1962 1913 2 2 19 2003 15 11 27 1935 10 3 1946 21 10 1947 22 4 1950 25 4 1958 33 4 1961 36 5 1980 55 3 4 36 5 Present Conditions of the Child Welfare Work in Japan., 1920

More information

Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho

Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical Scho Experimental and Clinical Studies of Pregnant Hypertension Takashi SHIMAZU Department of Obstetrics and Gynecology, Osaka City University Medical School While the problem of late pregnant hypertension

More information

Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID SRS GID GID GID GID GID QOL QOL QOL -- QOL

Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID SRS GID GID GID GID GID QOL QOL QOL -- QOL Core Ethics Vol. MTF Gender Identity Disorder GID GID GID GID QOL GID QOL QOL GID QOL GID QOL QOL QOL GID QOL Gender Identity Disorder QOL GID Core Ethics Vol. Sex Reassignment Surgery SRS SRS GID GID

More information

Special IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them

More information

TH-47LFX60 / TH-47LFX6N

TH-47LFX60 / TH-47LFX6N TH-47LFX60J TH-47LFX6NJ 1 2 3 4 - + - + DVI-D IN PC IN SERIAL IN AUDIO IN (DVI-D / PC) LAN, DIGITAL LINK AV IN AUDIO OUT 1 11 2 12 3 13 4 14 5 6 15 7 16 8 17 9 18 10 19 19 3 1 18 4 2 HDMI AV OUT

More information

ScanFront300/300P セットアップガイド

ScanFront300/300P セットアップガイド libtiff Copyright (c) 1988-1996 Sam Leffler Copyright (c) 1991-1996 Silicon Graphics, Inc. Permission to use, copy, modify, distribute, and sell this software and its documentation for any purpose is hereby

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,

More information

FA FA FA FA FA 5 FA FA 9

FA FA FA FA FA 5 FA FA 9 30 29 31 1993 2004 The process of the labor negotiations of Japan Professional Baseball Players Association, 1993 2004 ABE Takeru Graduate School of Social Science, Hitotsubashi University Abstract The

More information

MV X 5 6 Common Terminology Criteria for Adverse Events Grade 1 Grade Gy 16 QOL QOL 5 6 7, 8 9, VOL.3 NO

MV X 5 6 Common Terminology Criteria for Adverse Events Grade 1 Grade Gy 16 QOL QOL 5 6 7, 8 9, VOL.3 NO 乳がん患者の放射線皮膚炎に対するスキンケアの指導の実際 がん放射線療法看護認定看護師とがん放射線治療に携わる看護師との比較 Educating practice of skin care for radiodermatitis of breast cancer patients: Comparison of the nurses with certified nurse in radiation therapy

More information

日本消化器外科学会雑誌第31巻第7号

日本消化器外科学会雑誌第31巻第7号 Key words: obstructive jaundice, biliary drainage, bile refeeding, hepatectomy Fig. 1 Animal models a: experiment I b: experiment 2 silicon tube Fig. 2 Experimantal design Sham Ope J - l r bile duct Zweeks

More information

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 2-1. Summary of patients treated with grepafloxacin for respiratory infection 1) Out: outpatient,

More information

Special IssueCardiovascular therapeutics -Up-to-Date techniques and managements- Reviews Report Case reports Early treatment of acute myocardial infarction -chain of survival- Masataka Sata Department

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

スライド 1

スライド 1 医薬品副作用報告 中部ろうさい病院薬剤部 2016 年 4 月 1 日 1 中部ろうさい病院副作用報告の書式について 下記ダウンロードページにアクセスしていただき 必要なファイルをダウンロードしてください 書式のファイルは 副作用報告 のリンク先のページに置いてあります ダウンロードページURL http://www.chubuh.johas.go.jp/clinicaltrial/database/

More information

MIDI_IO.book

MIDI_IO.book MIDI I/O t Copyright This guide is copyrighted 2002 by Digidesign, a division of Avid Technology, Inc. (hereafter Digidesign ), with all rights reserved. Under copyright laws, this guide may not be duplicated

More information

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio 7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

More information

- 1 -

- 1 - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - 1 2 1-16 - 2 3 4 5 6 7-17 - 1 2 1 2 3 4-18 - 1 2 3 4 1 2-19 - 1 2 3 1 2-20 - 3 4 5 6 7 1-21 - 1 2 3 4-22

More information

CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Proteus mirabilis 3.13, Proteus vulgaris 1.56, Citrobacter freundii 0.39,

More information

9(2007).ren

9(2007).ren 1 Resignation (giving up): Meaning and Concept in Psychology Akira OHASHI 23 24 25 26 27 28 29 30 31 32 33 Resignation (giving up): Meaning and concept in psychology Akira OHASHI This study dealt with

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c

Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic clinic, Department of Ophthalmology, (Director: Prof

More information

ScanFront 220/220P 取扱説明書

ScanFront 220/220P 取扱説明書 libtiff Copyright (c) 1988-1996 Sam Leffler Copyright (c) 1991-1996 Silicon Graphics, Inc. Permission to use, copy, modify, distribute, and sell this software and its documentation for any purpose is hereby

More information

ScanFront 220/220P セットアップガイド

ScanFront 220/220P セットアップガイド libtiff Copyright (c) 1988-1996 Sam Leffler Copyright (c) 1991-1996 Silicon Graphics, Inc. Permission to use, copy, modify, distribute, and sell this software and its documentation for any purpose is hereby

More information

untitled

untitled SATO Kentaro Milk and its by-products are naturally nutritious food, and people in ancient Japan enjoyed tasting them as foods, drinks, or medicines. On the other hand, milk and its by-products were closely

More information

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI 20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old

More information

Special IssueTo save our life from myocardial infarction -what can we do before and after heart attack- Reviews Originals Case reports et al et al et al et al et al et al et al et al et al et al et

More information

不安障害研究, 9(1), 17-32, 2017

不安障害研究, 9(1), 17-32, 2017 9(1), 17 32, 2017 Panic and Agoraphobia Scale 1 2 3 2 2 2 2 4 4 1 2 3 4 Panic and Agoraphobia Scale PAS DSM-IV-TR APA, 2000 3 4 PAS PAS PAS Patient Global Impression Improvement PAS 1980 Diagnostic and

More information

The research,consciousness of the mother who used temporary child care at the day nursery MATSUOKA Tomoko, SAKURADANI Mariko Research for the mother who has the experience which temporary child care was

More information

PubMedとは

PubMedとは 7 1 PubMed 1994 4 1999 4 2004 4 7 PubMed PubMed http://www.ncbi.nlm.nih.gov/pubmed/ http://pubmed.gov National Library of Medicine; NLM PubMed NLM MEDLINE MEDLINE Index Medicus PubMed PubMed 1879 1964

More information

untitled

untitled CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11

More information

43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* 0 +0 2*,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * + +2 +2 +3,* 3 3 ++ +, 0.. /3 : +/,.

43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* 0 +0 2*,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * + +2 +2 +3,* 3 3 ++ +, 0.. /3 : +/,. 42 * :. +, / /0/ ha, +. 2, 2ha. + : :, / /0/ +3,2. 2 / * 43 + +* / +3+0,, 22*,, ++..0/ / 1/. / / + /* *,* +* *.* /* 0 +0 2*,/./ +3+,. + : / 3 / +** +**, // /. /+ /+ + * * + +2 +2 +3,* 3 3 ++ +, 0.. /3

More information

2708 日本 臨 床 外 科 学 会雑 誌 Table 1 Laboratory data 66巻 on admission Fig. 2: Gastrointestinal the left hollow hollow was endoscopy the was the afferent was

2708 日本 臨 床 外 科 学 会雑 誌 Table 1 Laboratory data 66巻 on admission Fig. 2: Gastrointestinal the left hollow hollow was endoscopy the was the afferent was 2708 日本 臨 床 外 科 学 会雑 誌 Table 1 Laboratory data 66巻 on admission Fig. 2: Gastrointestinal the left hollow hollow was endoscopy the was the afferent was the transverse Fig. 3: Abdominal demonstrated efferent

More information